Brief: Motus GI Enrolls Patients At Second Site In EU Outpatient Study Of Pure-Vu System
08/09/2021 13:20
Sept 8 (Reuters) - Motus GI Holdings Inc MOTS.O :
* MOTUS GI ANNOUNCES ENROLLMENT OF PATIENTS AT SECOND SITE
IN THE
EUROPEAN UNION OUTPATIENT STUDY OF THE PURE-VU® SYSTEM
Source text for Eikon: ID:nGNX33b5tH
Further company coverage: MOTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Motus GI Holdings
See all newsBrief: Motus GI Holdings Inc Continuing To Explore A Range Of Strategic And Financing Alternatives
Brief: Motus Gi Holdings Files Prospectus Related To Resale Of Up To 4.4 Million Shares Of Common Stock, By The Selling Stockholder
Brief: Motus GI Granted A U.S. Patent For Key Feature Embodied By The Pure-Vu System
U.S. STOCKS ON THE MOVE-Chewy, Amgen, Bluebird bio
Brief: Motus Gi Holdings Says Prices Public Offering At $1.50 Per Share